logo-cd28-rvb – Maison Sport Santé d'Eure-et-Loir
Fonctions de CD28, CTLA-4 et PD-1 - ScienceDirect
T-cell regulation by CD28 and CTLA-4 | Nature Reviews Immunology
Understanding the CD28/CTLA‐4 (CD152) Pathway and Its Implications for Costimulatory Blockade - Gardner - 2014 - American Journal of Transplantation - Wiley Online Library
CD28 family receptor - Wikipedia
Sialic Acid Ligands of CD28 Suppress Costimulation of T Cells | ACS Central Science
The B7–CD28 superfamily | Nature Reviews Immunology
FR104/VEL-101 - Ose Immunotherapeutics - Société de biotechnologie intégrée qui développe des immunothérapies innovantes
IVD Antibody Development Services for CD28 Marker - Creative Biolabs
Role of CD28 in PD-1-mediated inhibition and the rescue of exhausted T cells during PD-1-targeted therapy
Utilisation du bélatacept en transplantation rénale – Nephro.blog
T-cell Activation: The Purpose of CD28, CTLA-4, and CD80/CD86 | ProSci Incorporated
PD-1 & CD28 signalling in exhausted T cells and effect of PD-1/PD-L1... | Download Scientific Diagram
Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases | Annals of the Rheumatic Diseases
The Story of CD4+CD28− T Cells Revisited: Solved or Still Ongoing?
T-cell regulation by CD28 and CTLA-4 | Nature Reviews Immunology
CD28 Signaling Controls Metabolic Fitness of Pathogenic T Cells in Medium and Large Vessel Vasculitis | Journal of the American College of Cardiology
IVD Antibody Development Services for CD28 Marker - Creative Biolabs
B7 & CD28/CTLA-4 Receptor Families: R&D Systems
Combinatorial proteomic analysis of intercellular signaling applied to the CD28 T-cell costimulatory receptor | PNAS
CTLA-4/CD28 Signaling Pathway - Creative Diagnostics
CD28-ζ CAR T Cells Resist TGF-β Repression through IL-2 Signaling, Which Can Be Mimicked by an Engineered IL-7 Autocrine Loop: Molecular Therapy
IJMS | Free Full-Text | The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology
CD28 costimulation promotes an antitumor CD8+ T cell response in myeloid antigen-presenting cell niches | Cellular & Molecular Immunology
